Antituberculous therapy and acute liver failure.
Noble
A
A
D000995:Antitubercular Agents / Q000009:adverse effects*; D004348:Drug Labeling; D006501:Hepatic Encephalopathy / Q000139:chemically induced* / Q000175:diagnosis; D006801:Humans; D007538:Isoniazid / Q000009:adverse effects; D008111:Liver Function Tests
D000995:Antitubercular Agents; D007538:Isoniazid